Frederick C. Beddingfield III

Overview

Frederick C. Beddingfield III received an average of $2M in total compensation, including $423K in salary, at Sienna Biopharmaceuticals from 2016 to 2018.

Source: SEC filings on April 11, 2019 and April 19, 2018.

Related executives

We found four more executives who work or worked at Sienna Biopharmaceuticals.

John Smither

Sienna Biopharmaceuticals

Chief Financial Officer

Timothy Andrews

Sienna Biopharmaceuticals

General Counsel

Richard Peterson

Sienna Biopharmaceuticals

Chief Financial Officer

Todd Harris

Sienna Biopharmaceuticals

Head of Corporate Development

News

You may also like